All In Biotech

Free tool

FAERS Monitor: Vectibix

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125147 or its brand name (Vectibix, Panitumumab). Reports on generic versions are filed under their own applications.

Reports

16,106

Serious

14,116

88% of reports

Hospitalization

5,471

Death reported

2,738

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • rash1,979
  • diarrhoea1,649
  • dermatitis acneiform1,069
  • death1,060
  • neutropenia963
  • skin toxicity934
  • nausea863
  • colorectal cancer metastatic861
  • hypomagnesaemia849
  • disease progression749
  • neuropathy peripheral749
  • off label use743
  • fatigue719
  • dry skin717
  • vomiting663

Reports by year received

View as table
YearReports
20053
200626
2007315
2008326
2009334
2010359
2011601
2012524
2013489
2014625
2015709
2016962
2017965
20181,176
20191,241
20201,015
2021891
2022956
20231,169
20241,050
2025948
20261,422

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,038,053 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
colorectal cancer metastaticSignal861744.3685.5406,710
dermatitis acneiformSignal1,069278.0260.8243,149
skin toxicitySignal934258.3241.2199,713
hypomagnesaemiaSignal84984.779.265,912
neuropathy peripheralSignal74910.49.76,300
neutropeniaSignal9639.38.87,128
disease progressionSignal7498.37.74,808
dry skinSignal7177.06.63,718
rashSignal1,9796.05.78,282
diarrhoeaSignal1,6493.33.22,783
vomiting6631.81.7260
death1,0601.61.5253
nausea8631.41.3113
fatigue7191.21.126
off label use7431.11.08

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.